|
NCAPG2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.128140E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.282410E-02 |
| Normal-vs-Stage2 |
7.120300E-03 |
| Normal-vs-Stage3 |
2.286100E-02 |
| Normal-vs-Stage4 |
7.574600E-01 |
| Stage1-vs-Stage2 |
3.698000E-01 |
| Stage1-vs-Stage3 |
7.432400E-01 |
| Stage1-vs-Stage4 |
4.588600E-01 |
| Stage2-vs-Stage3 |
5.421800E-01 |
| Stage2-vs-Stage4 |
2.593400E-01 |
| Stage3-vs-Stage4 |
3.996000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.670240E-02 |
| Normal-vs-AfricanAmerican |
5.884400E-01 |
| Normal-vs-Asian |
4.175800E-02 |
| Caucasian-vs-AfricanAmerican |
2.855800E-01 |
| Caucasian-vs-Asian |
8.391600E-01 |
| AfricanAmerican-vs-Asian |
2.722000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.756260E-03 |
| Normal-vs-Female |
3.364300E-02 |
| Male-vs-Female |
1.563760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.280100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.711940E-02 |
| Normal-vs-Age(61-80Yrs) |
2.488500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.859200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.406200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.091000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.910800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.462200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.558600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.906800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.990000E-01 |
| Classical-VS-Follicular |
2.59020000004107E-06 |
| Classical-VS-Other |
5.232800E-01 |
| Classical-VS-Normal |
1.447230E-01 |
| Tall-VS-Follicular |
1.886020E-02 |
| Tall-VS-Other |
4.451600E-01 |
| Tall-VS-Normal |
8.826000E-01 |
| Follicular-VS-Other |
4.415200E-01 |
| Follicular-VS-Normal |
1.11879999997733E-06 |
| Other-VS-Normal |
1.561840E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.617500E-03 |
| Normal-vs-N1 |
4.865800E-01 |
| N0-vs-N1 |
6.096800E-01 |
|
|
